Angela Macfarlane

Active Investor

Chief Executive Officer at Perceive Biotherapeutics, Inc. at Perceive Biotherapeutics, Inc.

Menlo Park, California

Angela Macfarlane, Chief Executive Officer at Perceive Biotherapeutics, Inc. at Perceive Biotherapeutics, Inc. is an active investor based in Menlo Park, California. This profile covers what Angela Macfarlane backs, at which stage, and how founders can reach out in 2026.

Ms. Angela Macfarlane serves as Chief Executive Officer at Perceive Biotherapeutics. She serves as Chief Executive Officer at Perceive Pharma. Ms. Macfarlane served as Chief Executive Officer and President at ForSight Labs. She is an Angel Investor. Ms. Macfarlane co-founded and served as Chief Executive Officer & Board Member at ForSight VISION5. Ms. Macfarlane serves as a Board Director at Fogarty Innovation. She serves as an Advisor at Vensana Capital. She serves as a Board Member at Spiral Therapeutics. She is a Co-Founder and serves as Chief Executive Officer and Board Member at ForSight VISION5. She also serves as a Board Member at RenovoRx. founded and also serves as a Managing Partner of LLC an ophthalmic incubator formed in 2005 to focus on innovation in ophthalmology. ForSight has started eight companies in both therapeutics and medical devices - including Transcend Medical, Inc. (acquired by Alcon), ForSight Newco II, Inc. (acquired by QLT), NexisVision, Inc. (licensed), Forsight VISION4, Inc. (acquired by Roche - FDA approved SUSVIMO® ), ForSight VISION5, Inc. (acquired by Allergan), ForSight VISION6, Inc. (private/strategic partnership), Recognify Life Sciences (private/partnered with ATAI), and Boost Biotherapeutics (private). Ms. Macfarlane served as both the founding CEO for ForSight VISION4, Inc. through the acquisition by ROCHE, and the founding CEO of ForSight VISION5, Inc. and then at the acquisition by Allergan. Previously, Ms. Macfarlane served as Chief Technology Counsel to The Foundry, a medical technology incubator, and Technology Counsel for Thomas J. Fogarty, M.D., where she formed and developed 9 companies. She previously served on the senior management teams at TransVascular, Inc. (acquired by Medtronic), AneuRx, Inc. (acquired by Medtronic), and VidaMed Inc. (through IPO). Ms. Macfarlane is an inventor on 25 U.S.-issued patents and received her BA in Business Administration from San Francisco State University, and her J.D. from Golden Gate University School of Law. She currently serves on the board of Perceive Biotherapeutics, ForSight VISION6, Inc., RenovoRx (NASDAQ: RNXT) Recognify Life Sciences, and Fogarty Innovation (non-profit).

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected Devices
Location: Menlo Park, California
Typical check: $500K
Past investments: 3

Notable investments

RenovoRxFogarty InnovationNextGen Jane

How to reach Angela Macfarlane

Angels and operators like Angela Macfarlane reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Angela Macfarlane invest in?

Angela Macfarlane invests in Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices and SaaS & Enterprise, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.